Kalaris Therapeutics Inc
Price Action
Technical Summary
WEAKENINGKalaris Therapeutics Inc is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 13), showing significant lag compared to the market leaders. Earnings growth of 82% provides fundamental context to the price action. Investors should exercise caution due to high volatility (108% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $4.43 | -4.91% | BELOW |
| 50 SMA | $5.01 | -15.79% | BELOW |
| 100 SMA | $6.57 | -35.84% | BELOW |
| 150 SMA | $7.17 | -41.24% | BELOW |
| 200 SMA | $6.67 | -36.83% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is KLRS in an uptrend right now?
KLRS has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is KLRS overbought or oversold?
KLRS's RSI (14) is 44. The stock is in neutral territory, neither overbought nor oversold.
Is KLRS outperforming the market?
KLRS has a Relative Strength (RS) Rating of 13 out of 99. KLRS is currently lagging the broader market.
Where is KLRS in its 52-week range?
KLRS is trading at $4.21, which is 35% of its 52-week high ($11.88) and 21% above its 52-week low ($2.14).
How volatile is KLRS?
KLRS has a Beta of 0.64 and 52-week volatility of 108%. It's less volatile than the S&P 500 - generally more stable.